https://www.selleckchem.com/products/ki20227.html
05). However, lopinavir/ritonavir showed better efficacy than arbidol for the same outcomes (P0.05). Lopinavir/ritonavir plus arbidol was effective compared to arbidol alone in terms of the negative rate of PCR on day 7 (P=0.02). However, this difference was not significant regarding other efficacy outcomes (P0.05). Lopinavir/ritonavir has no more treatment effects than other therapeutic agents used herein in COVID-19 patients. Lopinavir/ritonavir has no more treatment effects than other therapeutic agents used herein in COVID-1
Like
Comment
Share
